Abstract. Matrix metalloproteinases (MMPs) are enzymes that play an important role in degradation and remodeling of extracellular matrix and MMP-2 has been also shown as a primary mediator of the acute mechanical dysfunction of the heart immediately after ischemia/reperfusion (I/R). The aims of the study were to investigate the influence of I/R on MMP-2 and to study the effects of wortmannin on modulation of MMP-2 activities after cycle of short I/R procedures (ischemic preconditioning, IP). Wortmannin is a specific inhibitor of PI3K/Akt kinase pathway activation of which was found to play a role in infarct size limiting mechanisms in the rat heart. In the study isolated Langendorff-perfused rat hearts subjected to protocols of prolonged (test) I/R and/or IP were used. Wortmannin was infused before and during the reperfusion phase of IP. The levels and activation of proteins were determined by immunoblot assay. The MMP-2 activities were measured by zymography. We found that ischemia induced time-dependent activation of tissue pro-MMP-2. Strong activation occurred after 15 min ischemia, during prolonged ischemia and following reperfusion the activities of this form of MMP-2 declined. The specific activities of both 72 and 63 kDa forms of MMP-2 were increased in perfusates collected during reperfusion after 30 min ischemia and these activities peaked in the first minute of reperfusion. Cycle of short ischemia and reperfusion that led to increased cardiac tolerance against prolonged I/R reduced 72 kDa MMP-2 activities and induced also an activation of Akt kinase. The application of wortmannin was connected with inhibition of IP-mediated Akt kinase activation. Moreover, the actions of wortmannin were linked with modulation of MMP-2 activities. Our results suggest that MMP-2 may be involved in the responses of rat hearts to ischemia and point to possible relationship between Akt kinase and modulation of MMP-2 activities in rat hearts.
Introduction
The exposure of myocardium to episodes of short ischemia followed by reperfusion leads to increased resistance of the heart against subsequent potentially lethal long-term ischemia (Murry et al. 1986; Kloner and Jennings 2001) . This phenomenon is known as ischemic preconditioning (IP) and several studies documented that cardioprotective effects similar to IP can also be induced pharmacologically by substances such as sildenafil, diazoxide (Kukreja et al. 2005; Šimončíková et al. 2007) . Results of our recent study showed that the effects of diazoxide on reduction of myocardial injury after ischemia/reperfusion (I/R) in rat hearts were associated with an inhibition of matrix metalloproteinase-2 activities (Šimončíková et al. 2007 ). Matrix metalloproteinases (MMPs) belong to the family of zinc-dependent endopeptidases which are synthesized as zymogens and are activated by proteolytic cleavage of an amino-terminal domain (Birkedal-Hansen 1995) or through conformational changes induced by oxidative stress (without a change in molecular weight) (Okamoto et al. 1997) . These enzymes play an important role in degradation and remodeling of extracellular matrix under physiological and pathological conditions (Peterson et al. 2001) . Moreover, it was found that MMP-2 activation also resulted in the degradation of specific proteins, including troponin I (Wang et al. 2002b) , myosin light chain (Sawicki et al. 2005 ) and α-actinin (Sung et al. 2007) . These data implicate some MMPs in modulation of acute physiologically relevant processes and for example MMP-2 has been shown as a primary mediator of the acute mechanical dysfunction of the heart immediately after ischemia and reperfusion (Cheung et al. 2000) . Mechanisms that participate in injury induced by I/R involve also generation of oxidative stress in early phase of reperfusion after ischemia. The formed reactive oxygen species can trigger cascades of pathophysiological events, including activation of MMPs. This is supported also by findings that peroxynitrite, the reaction product of NO and superoxide, can activate proteolytic activity of pro-MMP-2 against several substrates including gelatin and troponin I (Viappiani et al. 2006 (Viappiani et al. , 2009 . Peroxynitrite was also found to stimulate an acute release of MMP-2 from rat hearts during reperfusion (Cheung et al. 2000) .
Several studies demonstrated that the expression and activation of MMPs is regulated through protein kinase cascades such as ERKs (Kurata et al. 2000) and PI3K/Akt (Bae et al. 2006) . These signaling pathways were also found to play an important role in responses of heart to I/R and in the mechanisms of heart adaptation to pathological situations (Strohm et al. 2000; Strnisková et al. 2006) . PI3K/Akt kinase cascade is implicated in processes of cell survival and metabolic control, and its activation was also found to play a role in infarct size limiting mechanisms in the rat heart .
We have recently shown that positive changes in ischemic cardiac tolerance induced by pharmacological preconditioning (Šimončíková et al. 2007 ) and observed after development of chronic NO deficiency (Špániková et al. 2008) were connected with an inhibition in MMP-2 in the rat heart. This pointed to the role of this enzyme in responses of rat heart to I/R and in mechanisms of cardioprotection. Since Akt kinase activation was found to play an important role during ischemia and in cardioprotective adaptive responses in rat hearts, we suggested that the changes in MMP-2 could also be related to this kinase pathway. Thus, the aim of our present study was to investigate the effects of I/R as well as procedure of IP on MMP-2. Furthermore, to elucidate the possible relation between MMP-2 and PI3K/Akt kinase pathway during IP the effects of specific inhibitor of PI3K/ Akt kinase pathway (wortmannin) on IP-induced changes in MMP-2 were determined.
Materials and Methods

Experimental model
In the study, adult male Wistar rats (250-280 g body weight) were used. All animals had free access to water and a standard laboratory diet. The study was performed in accordance with Guide for Care and Use of laboratory animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1996) and approved by the Animal Care and Use Committee of the Slovak Republic.
Perfusion technique
Rats were anesthetized (sodium pentobarbitone, 60 mg/kg, i.p.) and given heparin (500 IU, i.p.). Hearts were rapidly excised, placed in ice-cold perfusion buffer, cannulated via the aorta and perfused in the Langendorff mode at a constant perfusion pressure of 70 mmHg and at 37ºC. Perfusion solution was a modified Krebs-Henseleit buffer gassed with 95% O 2 and 5% CO 2 (pH 7.4) containing (in mmol/l): NaCl 118.0; KCl 3.2; MgSO 4 1.2; NaHCO 3 25.0; KH 2 PO 4 1.18; CaCl 2 2.5; glucose 7.0. Solution was filtered through a 5 µm porosity filter (Millipore) to remove contaminants.
Experimental protocols
The Langendorff-perfused hearts were allowed to stabilize (20 min) before further interventions. In the protocol of test ischemia the hearts were exposed to 30 min global ischemia induced by stop of aortal inflow and 40 min reperfusion. Tissue samples from the left ventricle were collected at the beginning (before the test ischemia), at different time points of ischemia (5, 15, 30 min) and during the following reperfusion (10, 20 min). All tissue samples were frozen in liquid nitrogen and stored at -75°C until further analysis. Perfusates were collected after stabilization (before ischemia) and during reperfusion that followed the preceding ischemia. All samples were stored at -75°C until further analysis.
The protocol of IP was evoked by one cycle of short 5 min ischemia and 5 min reperfusion. In drug studies, wortmannin (100 nmol/l) was applied 5 min before and during reperfusion phase of IP protocol. Tissue samples from the left ventricle were collected at the beginning (before the first short ischemia) and at the end of IP procedure. All tissue samples were frozen in liquid nitrogen and stored at -75°C until further analysis.
Preparation of protein fractions
The tissue samples from left ventricle were wiped in liquid nitrogen, resuspended in ice-cold buffer A containing (in mmol/l): 20 Tris-HCl, 250 sucrose, 1.0 EGTA, 1.0 dithiothreitol (DTT), 1.0 phenylmethylsulfonylfluoride (PMSF) and 0.5 sodium orthovanadate (pH 7.4) and homogenized with a Teflon glass homogenizer. The homogenates were centrifuged at 800 × g for 5 min at 4°C and the supernatants after this centrifugation were centrifuged again at 16 100 × g for 30 min. The postmitochondrial supernatants after this second centrifugation were used for further analysis. The protein concentrations were estimated by the method of Bradford (Bradford 1976) .
Preparation of perfusates
To investigate the influence of ischemia on release of metalloproteinases from tissue into circulation, perfusates were collected before the onset of ischemia (at the end of stabilization) and at 1, 5, 10 and 20 min of reperfusion that followed the 30 min ischemia. The perfusates were dialysed overnight against redistilled water (at 4°C). After dialysis, samples were freeze-dried, resuspended in 300 µl of 20 mmol/l Tris-HCl (pH 7.40) and used for preparation of electrophoretic samples to gelatin zymography and Western blot analysis.
Electrophoresis and immunochemical Western blot analysis
Protein fractions containing equivalent amounts of ventricular proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). Total contents or activation of proteins were determined by Western blot analysis using specific antibodies. For Western blot assays, proteins after electrophoretic separation were transferred to nitrocellulose membrane. The quality of transfer was controlled by Ponceau S staining of nitrocellulose membranes after transfer and protein loading by using glyceraldehyde-3-phosphate dehydrogenase (GAPH) as a housekeeper. Specific anti-Akt kinase, anti-MMP-2, anti-GAPDH (all from Santa Cruz Biotechnology), anti-phospho-Akt kinase (from Cell Signaling Technology) antibodies were used for primary immunodetection. Peroxidase-labelled anti-rabbit immunoglobulin (Cell Signaling Technology) was used as the secondary antibody. Bound antibodies were detected by the enhanced chemiluminescence (ECL) detection method.
Measurement of MMP activities by gelatin zymography
The gelatinolytic activities of MMPs were determined by the modified method of Schonbeck et al. (1997) . Laemmli buffer without 2-mercaptoethanol in proportion 1 : 1 was added to protein samples and non-heated samples were subjected to electrophoresis on 10% SDS-polyacrylamide gels co-polymerized with gelatin (2 mg/ml). After electrophoresis, gels were washed twice for 20 min each with 50 mmol/l Tris-HCl (pH 7.4), containing 2.5% Triton X-100, at 25°C. After washing, the gels were incubated overnight at 37°C in substrate buffer containing 50 mmol/l Tris-HCl, 10 mmol/l CaCl 2 and 1.25% Triton X-100, pH 7.4. After this incubation, the gels were stained with 1% Coomassie Brilliant Blue G-250, resolved in mixture of methanol : acetic acid : water (4 : 1 : 5) for 2 hours at room temperature and then destained with 40% methanol and 10% acetic acid. Gelatinolytic activities of MMP-2 were detected as transparent bands against dark blue background.
Statistical evaluation
Quantification of protein levels was done using Phosphorimager Thyphoon (Amersham Biosciences). Data were expressed as means ± S.E.M. Statistical significance of differences between the groups was analysed by the unpaired Student's t-test. Differences were considered significant at p < 0.05.
Results
Effect of I/R on levels and activities of MMP-2
Protein levels of tissue MMP-2 we determined using specific antibody that reacts with a 72 kDa (pro-MMP-2) and 63 kDa form of MMP-2. The results showed no significant differences in the levels of these MMP-2 forms between tissue of control hearts and hearts after ischemia and reperfusion (Fig. 1A) . Activities of MMPs were analyzed by zymography using gelatin as a substrate. As a positive control for identification of 63 kDa MMP-2 we used recombinant active MMP-2 (Calbiochem) and pro-MMP-2 was identified using fetal bovine serum containig predominantly activity of this 72 kDa form of MMP-2. In tissue samples we detected predominantly enzymatic gelatinolytic activities of oxidatively activated 72 kDa form of MMP-2 and we found activation of this form of enzyme induced by ischemia (Fig. 1B,D) . Strong activation occurred after 15 min of ischemia, during prolonged 30 min ischemia and the following reperfusion the activation of this enzyme declined. For 63 kDa (proteolytically activated) form of MMP-2, we did not observe intensive gelatinolytic bands and I/R also did not induce an activation of this form of MMP-2.
Effect of I/R on release of MMP-2 into circulation
The release of MMP-2 was analysed in perfusates which were sampled during reperfusion that followed 30 min lasting ischemia. Gelatin zymography of perfusates showed gelatinolytic activity corresponding to both 72-and 63-kDa forms of MMP-2. After 1 min of reperfusion both 72 and 63 kDa MMP-2 activities were significantly increased in comparison to perfusates obtained before ischemia ( Fig. 2A,C,D) . During prolonged reperfusion the activities of both forms of MMP-2 declined. Increased MMP-2 activities after 1 min of reperfusion were accompanied by significant increases in protein levels as measured by Western blot analysis (Fig. 2B) .
Effect of I/R on MMP-2
To explore the influence of short cycle of ischemia and reperfusion (IP procedure) on the protein levels and activities of MMP-2, we performed Western blot analysis and zymography of heart ventricular tissue samples taken before (control) and after IP procedure. The results obtained using antibody that reacts with 72 kDa and 63 kDa forms of MMP-2 showed no significant differences in the levels of these MMP-2 forms between tissue of control and preconditioned hearts (Fig. 3A) . On the other hand, in preconditioned hearts exposed to cycle of 5 min ischemia and 5 min reperfusion we found significant reduction of gelatinolytic activity of 72 kDa MMP-2 (Fig. 3B,C) .
Effect of PI3K/Akt kinase pathway inhibitor on IP-mediated changes in Akt kinase
Analysis with the antibody specific for Akt kinase revealed no differences in the levels of Akt kinase between the control and preconditioned rat hearts (Fig. 4A) . Also the application of wortmannin did not influence the Akt kinase levels (Fig. 4A) . On the other hand, detection with a phosphospecific antibody (Ser473) showed increased phosphorylation (activation) of Akt kinase in the preconditioned hearts as compared with non-preconditioned controls (Fig. 4B,C) . Application of wortmannin reversed the IP-mediated effects on Akt kinase and we found significant inhibition of the IP-mediated Akt kinase phosphorylation (activation) (Fig. 4B,C) .
Effect of PI3K/Akt kinase pathway inhibitor on IP-mediated changes in MMP-2
Analysis of MMP-2 activities by zymography in gels containing gelatin as a substrate showed that IP reduced the activities of 72 kDa form MMP-2 and application of wortmannin (Fig. 5A,B) reversed the IP-mediated effects on activities of this form of MMP-2. Analysis with the specific antibody showed that these changes in MMP-2 activities were not associated with modulation of protein levels (Fig. 5C ).
Discussion
In the present study, we showed that cycle of short ischemia and reperfusion that lead to increased cardiac tolerance against prolonged I/R induced an activation of Akt kinase and reduced MMP-2 activities. The results also show that application of inhibitor of PI3K/Akt kinase pathway was connected with inhibition of IP-mediated Akt kinase activation and the effects of wortmannin were also linked with modulation of MMP-2 activities. Furthermore, we have shown that ischemia induced time dependent activation of 72 kDa form of tissue MMP-2 and immediately after start of reperfusion both 72 and 63 kDa MMP-2 activities were significantly increased in heart perfusates. The present study also added evidence to possible relationship between Akt kinase and modulation of MMP-2 activities during IP. MMPs are zinc-dependent endopeptidases that play an important role in degradation and remodeling of extracellular matrix under physiological and pathological conditions (Peterson et al. 2001) . The findings that MMP-2 activation is involved in the degradation of proteins unrelated to extracellular matrix, such as troponin I, myosin light chain, α-actinin (Wang et al. 2002b; Sawicki et al. 2005; Sung et al. 2007), implicate this enzyme in a variety of acute physiologically relevant processes. The inhibition of MMP-2 after procedure of IP observed in our study might also suggest that modulation of activities of this enzyme can be involved in the mechanisms responsible for increased tolerance of preconditioned rat hearts against I/R injury. To the possible role of MMP-2 in cardioprotection produced by preconditioning point also the results of study of Lalu et al. (2002) . In this was shown that preconditioning of rat hearts with three brief periods of no flow ischemia significantly decreased the activation and release of tissue MMP-2 into the perfusate after test I/R. Our results showed that tissue pro-MMP-2 activation is reduced already at the end of cycles of short ischemia and reperfusion, before the following test ischemia. Similar down-regulation of MMP-2 activities before start of test ischemia we found recently also after pharmacological preconditioning induced by diazoxide (Šimončíková et al. 2007 ). This suggests that important role in mechanisms of cardioprotection induced by these different forms of short-term adaptation procedures plays the observed reduction of MMP-2 activities at the beginning of test ischemia. Inhibition of MMP using inhibitors may provide benefits in the treatment of cardiac diseases through protecting cardiac myocytes and also by protecting the integrity of endothelium and possibly intracellular membranes (Fert-Bober et al. 2008) . To the significant role of MMP-2 in processes associated with I/R point our data showing the time-dependent changes of MMP-2 activities during prolonged ischemia and release of the active enzyme into the effluent during the following reperfusion. Negative role of MMP-2 during ischemia was documented in studies showing that MMP-2 is a primary modulator of the acute mechanical dysfunction of the heart following ischemia and reperfusion and inhibition of its activity significantly improved cardiac function (Cheung et al. 2000; Wang et al. 2002a ).
In heart tissue of left ventricle we identified the 72 and 63 kDa forms of MMP-2 by Western blot analysis. The 72 kDa form corresponds to pro-MMP-2 (zymogen) and 63 kDa MMP-2 is active form of enzyme which is a product of proteolytic cleavage of pro-MMP-2. By zymography of tissue samples we detected mainly the gelatinolytic activity corresponding to molecular weights of 72 kDa and despite the observed changes in gelatinolytic activity we did not observe changes in tissue protein content of this enzyme. The observed activity of 72 kDa form corresponds to pro-MMP-2 activated through conformational changes induced by oxidative stress. It is suggested that powerful endogenous oxidant, such as peroxynitrite, can activate MMPs by reacting with a critical cysteine residue without loss of the propeptide (Okamoto et al. 2001) . Thus, the changes in myocardial peroxynitrite biosynthesis may influence the MMP-2 activity without changes of pro-peptide or changes in expression. Ischemia and reperfusion are associated with generation of oxygen free radicals, including superoxide and peroxynitrite (Bolli and Marban 1999) . It was also documented that the biosynthesis of peroxynitrite in the heart is greatly enhanced during the first minute of reperfusion after ischemia (Yasmin et al. 1997) . We found that at the first minute of reperfusion peaked also the activities of pro-MMP-2 and 62 kDa MMP-2 that were released to the perfusates. These results indicate that formation of peroxynitrite can contribute to the pro-MMP-2 activation.
In agreement with this are also the results of study where the reduction of endogenous peroxynitrite formation in the consequence of preconditioning has been observed (Csonka et al. 2001 ) and in our study observed inhibition of 72 kDa MMP-2 at the end of IP procedure. Moreover, in recent study we observed that in consequence of NO synthases activities inhibition by L-NAME also MMP-2 activities are down-regulated (Špániková et al. 2008) . We found that procedure of IP induced in addition to observed inhibition of MMP-2 activities also an activation of Akt kinase. Similarly to our finding, also other study documented increased phosphorylation of Akt kinase during acute IP (Tong et al. 2000) . Moreover, PI3K/Akt kinase pathway has been implicated in the mechanisms of various forms of cardioprotection (short-term and long-term), such as classical ischemic or hypoxic preconditioning and its delayed (second window) phase, as well as pharmacologically induced preconditioning Uchiyama et al. 2004; Ravingerová et al. 2007 ). The present study documented that application of wortmannin, inhibitor of PI3K/Akt kinase pathway, abolished the IP-induced changes in modulation of both Akt kinase and MMP-2 activities in rat hearts. Thus, the observed changes in MMP-2 during IP may be related to changes in activation of pro-survival PI3K/Akt kinase cascade. Some other studies demonstrated also a link between PI3K/Akt kinase pathway and regulation of MMPs expression and activation but in contrast to our data obtained after IP, the results showed that the induction of Akt kinase activation resulted in up-regulation of MMPs (Bae et al. 2006; Lee et al. 2007 ). Lee at al. (2007) found that high amount of glucose (25 mmol/l) induced enhanced production and zymographic activity of MMP-2 in adventitial fibroblasts prepared from the mice thoracic aorta. This MMP-2 production was attenuated by inhibition of PI3K/Akt pathway and the results showed that the effects of Akt kinase on MMP-2 were realized through enhanced activity of MMP-2 promoter and activation of gene transcription. Positive influence of PI3K/Akt kinase pathway on induction of MMP-2 expression was found also in gastric cancer cells (Bae et al. 2006) . In contrast to results of these studies, despite the changes in gelatinolytic activity we did not observe changes in expression, production of MMP-2 and the effects of Akt kinase were not realized at the transcriptional level. Important is also fact that changes observed in our study (after IP) were realized in short time -within several minutes. On the other hand, Lee et al. (2007) documented the effects of PI3K/Akt pathway inhibition on MMP-2 after prolonged time (24 h). This suggests that the observed discrepancies in role of Akt kinase by MMP-2 regulation can be attributed to substantial differences in mode of action of Akt kinase at different time and experimental models.
In summary, we have demonstrated that prolonged I/R induced activation of MMP-2. On the other hand, the procedure of IP resulted in inhibition of MMP-2 activities and this was associated with an activation of Akt kinase. Furthermore, the inhibition of Akt kinase resulted in reversal of IP-mediated inhibition of MMP-2 activities. The results indicate that MMP-2 may be involved in the responses of rat hearts to ischemia and modulation of its activities by Akt kinase may occur during the procedure of IP.
